Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Translational Development Acquisition (TDAC) Net Income (2024 - 2026)

Translational Development Acquisition's Net Income history spans 3 years, with the latest figure at $1.3 million for Q1 2026.

  • On a quarterly basis, Net Income fell 10.13% to $1.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $6.1 million, a 331.06% increase, with the full-year FY2025 number at $6.4 million, up 9059.65% from a year prior.
  • Net Income came in at $1.3 million for Q1 2026, down from $1.5 million in the prior quarter.
  • The five-year high for Net Income was $1.7 million in Q3 2025, with the low at -$61283.0 in Q3 2024.
  • Historically, Net Income has averaged $937358.2 across 3 years, with a median of $1.4 million in 2025.
  • Biggest five-year swings in Net Income: skyrocketed 96440.77% in 2025 and later fell 10.13% in 2026.
  • Year by year, Net Income stood at -$8044.0 in 2024, then soared by 18381.24% to $1.5 million in 2025, then dropped by 9.37% to $1.3 million in 2026.
  • Business Quant data shows Net Income for TDAC at $1.3 million in Q1 2026, $1.5 million in Q4 2025, and $1.7 million in Q3 2025.